Patents by Inventor Antoine Leimgruber

Antoine Leimgruber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determining a Cancer Prognosis
    Publication number: 20250116669
    Abstract: Provided herein are methods of determining the aggressiveness, prognosis and response to therapy for cancer, such as non-small cell lung carcinoma (NS-CLC), which includes determining an expression level of one or a plurality of differentially expressed protein markers in an exosome sample from a subject. A method and agent for treating cancer are also provided.
    Type: Application
    Filed: May 13, 2024
    Publication date: April 10, 2025
    Inventors: Richard Lobb, Antoine Leimgruber, Andreas Möller
  • Determining a Cancer Prognosis
    Publication number: 20200057068
    Abstract: Provided herein are methods of determining the aggressiveness, prognosis and response to therapy for cancer, such as non-small cell lung carcinoma (NSCLC), which includes determining an expression level of one or a plurality of differentially expressed protein markers in an exosome sample from a subject. A method and agent for treating cancer are also provided.
    Type: Application
    Filed: November 24, 2017
    Publication date: February 20, 2020
    Inventors: Richard Lobb, Antoine Leimgruber, Andreas Möller